Stock Scorecard
Stock Summary for SNDL Inc (SNDL) - $1.95 as of 4/25/2024 9:14:30 PM EST
Total Score
14 out of 29
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for SNDL
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for SNDL
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for SNDL
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for SNDL
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for SNDL
Financial Details for SNDL
Company Overview |
|
---|---|
Ticker | SNDL |
Company Name | SNDL Inc |
Country | USA |
Description | Sundial Growers Inc. is dedicated to the production and marketing of cannabis products for the adult use market in Canada. The company is headquartered in Calgary, Canada. |
Sector Name | LIFE SCIENCES |
Industry Name | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/13/2024 |
Stock Price History |
|
Last Day Price | 1.95 |
Last Day Price Updated | 4/25/2024 9:14:30 PM EST |
Last Day Volume | 1,482,845 |
Average Daily Volume | 8,660,641 |
52-Week High | 2.67 |
52-Week Low | 1.25 |
Last Price to 52 Week Low | 56.00% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 13.32 |
Sector PE | 61.73 |
5-Year Average PE | -1.58 |
Free Cash Flow Ratio | 2.64 |
Industry Free Cash Flow Ratio | 55.72 |
Sector Free Cash Flow Ratio | 30.74 |
Current Ratio Most Recent Quarter | 3.94 |
Total Cash Per Share | 0.74 |
Book Value Per Share Most Recent Quarter | 4.61 |
Price to Book Ratio | 0.59 |
Industry Price to Book Ratio | 2.22 |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 0.58 |
Industry Price to Sales Ratio Twelve Trailing Months | 1.19 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
Total Shares Outstanding | 263,084,000 |
Market Capitalization | 513,013,800 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 53.64% |
Reported EPS 12 Trailing Months | -0.47 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | -1.70 |
Net Income Twelve Trailing Months | -181,125,000 |
Net Income Past Year | -172,660,000 |
Net Income Prior Year | -372,428,000 |
Quarterly Revenue Growth YOY | 3.30% |
5-Year Revenue Growth | 85.64% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 195,041,000 |
Total Cash Past Year | 195,041,000 |
Total Cash Prior Year | 279,586,000 |
Net Cash Position Most Recent Quarter | 174,836,000 |
Net Cash Position Past Year | 195,041,000 |
Long Term Debt Past Year | 0 |
Long Term Debt Prior Year | 16,227,000 |
Total Debt Most Recent Quarter | 20,205,000 |
Equity to Debt Ratio Past Year | 1.00 |
Equity to Debt Ratio Most Recent Quarter | 0.98 |
Total Stockholder Equity Past Year | 1,212,069,000 |
Total Stockholder Equity Prior Year | 1,306,499,000 |
Total Stockholder Equity Most Recent Quarter | 1,212,069,000 |
Options |
|
Put/Call Ratio | 0.13 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.06 |
MACD Signal | 0.10 |
20-Day Bollinger Lower Band | 1.09 |
20-Day Bollinger Middle Band | 1.61 |
20-Day Bollinger Upper Band | 2.12 |
Beta | 3.41 |
RSI | 53.30 |
50-Day SMA | 1.58 |
200-Day SMA | 4.45 |
System |
|
Modified | 4/25/2024 11:49:14 AM EST |